| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue from operations | 17.2 | 10.8 | 7.5 |
| Other income | 0.2 | 0.1 | 0.2 |
| Total income | 17.4 | 11.0 | 7.6 |
| Profit before exceptional items & tax | 2.3 | 0.9 | 0.2 |
| Profit before tax | 2.3 | 0.9 | 0.2 |
| Net profit | 1.7 | 0.5 | 0.2 |
| Operating margin | 13.2% | 8.2% | 2.6% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +750.00% |
|---|---|
| Net profit, quarter on quarter | +240.00% |
| Revenue, year on year | +129.30% |
| Operating profit, quarter on quarter | +162.50% |
NSE results filing, NSE: ARVEE. Figures extracted from the filing.
Arvee Laboratories (India) Ltd: key numbers
- Share price
- ₹211.79
- Market cap
- ₹233.4 Cr
- Revenue (annual)
- ₹31.51 Cr
- Net profit (annual)
- ₹2.53 Cr
- P/E (TTM)
- 57.6×Sector 36.8×
- Promoter holding
- 73.50%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arvee Laboratories (India) Ltd
All →Arvee Laboratories (India) Management Change
Arvee Laboratories announced the resignation of Raina Singh as Company Secretary and Compliance Officer, effective September 9, 2026.
Arvee Laboratories (India) Board Meeting Date
Arvee Laboratories (India) Limited has scheduled a board meeting for August 7, 2026. The agenda includes reviewing quarterly standalone unaudited financial results and a scheme of arrangement.
Arvee Laboratories (India) Board Meeting Date
Arvee Laboratories (India) Limited has scheduled a Board Meeting for May 18, 2026, to approve the audited standalone financial results for the year ended March 2026. The company also confirmed that the trading window for designated persons has been closed since April 1, 2026.
Arvee Laboratories (India) Board Meeting Date
Arvee Laboratories (India) Limited has scheduled a board meeting on May 18, 2026, to consider and approve the audited standalone financial results for the year ended March 31, 2026. The trading window for designated persons remains closed until May 20, 2026.
Arvee Laboratories (India) Price Movement Clarification
Arvee Laboratories (India) Limited clarified to NSE that there are no undisclosed material events affecting its share price. The company confirmed compliance with SEBI Listing Regulations, stating price movement is solely determined by market forces and shareholders. No internal developments require disclosure at this time.
Arvee Laboratories (India) Q3 FY26 Results: Net Profit ₹1.8 Cr, Up 800.0% YoY
Arvee Laboratories (India) Ltd reported net profit of ₹1.8 Cr (+800.0% YoY) for Q3 FY26.
- Key figure
- Net profit ₹1.8 Cr · +800.0% YoY